Carey Thomas D. bought LAB
February 26, 2026 · Form 4 insider transaction
Carey Thomas D. bought 51,282 shares of Standard BioTools Inc. at $1.17 per share, a transaction worth $60.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,282
Price
$1.17
Total value
$60.0K
InsiderCarey Thomas D.
RoleDirector
CompanyStandard BioTools Inc. (LAB)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMarch 2, 2026
Shares owned after245,340
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date.; The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member.